Diagnostic and Prognostic Value of Multimodal MRI in Transient Ischemic Attack

2013 ◽  
Vol 9 (7) ◽  
pp. 895-901 ◽  
Author(s):  
Hyun-Wook Nah ◽  
Sun U. Kwon ◽  
Dong-Wha Kang ◽  
Deok-Hee Lee ◽  
Jong S. Kim
2020 ◽  
Vol 8 (2) ◽  
Author(s):  
Mengjiao Wei

 Symptomatic atherosclerotic intracranial artery stenosis often causes ischemic cerebral infarction or transient ischemic attack in the stenosis area. Early detection of cerebral infarction and evaluation of ischemic penumbra and hemodynamics in the infarct area Information plays an extremely important role in clinical treatment and prognosis. This article briefly introduces the application of multimodal MRI in cerebral infarction.


2021 ◽  
Vol 11 (2) ◽  
pp. 590-594
Author(s):  
Aixia Song ◽  
Jing Chen ◽  
Yan Sun ◽  
Xiaoqin Wang ◽  
Jichao Zhang ◽  
...  

Objective: To investigate the clinical effects of intravenous thrombolysis in the treatment of TIA (Transient Ischemic Attack) and cerebral infarction with multimodal MRI (magnetic resonance imaging), and to provide a reference for clinical diagnosis and treatment. Methods: Patients with acute cerebral infarction diagnosed and treated with intravenous thrombolysis were enrolled in the study. Multimodal MRI was performed to determine the location and type of cerebral infarction. Based on routine treatment and care, the rt-PA (Recombinant Tissue Plasminogen Activator) intravenous thrombolytic therapy was applied. The NIHSS (National Institutes of Health Stroke Scale) scores of patients before and after treatment were evaluated and compared to analyze the neurological prognosis. Results: The NIHSS scores after treatment were significantly lower than those before treatment, and the neurological prognosis was good. Three different forms of ACVS (asymmetric cortical venous signs) after treatment could be observed by SWI (drug-sensitive weighted imaging) images, which could help to assess the prognosis. Conclusion: Multimodal MRI could evaluate the type and severity of acute cerebral infarction. The rt-PA intravenous thrombolytic therapy could effectively promote the recovery of neurological functions in patients with cerebral infarction, which was worthy of clinical promotion.


BMC Neurology ◽  
2010 ◽  
Vol 10 (1) ◽  
Author(s):  
Katrin Holzer ◽  
Regina Feurer ◽  
Suwad Sadikovic ◽  
Lorena Esposito ◽  
Angelina Bockelbrink ◽  
...  

2021 ◽  
Vol 11 (2) ◽  
pp. 584-589
Author(s):  
Aixia Song ◽  
Jing Chen ◽  
Yan Sun ◽  
Xiaoqin Wang ◽  
Jichao Zhang ◽  
...  

Objective: To investigate the therapeutic effect of intravenous thrombolysis on TIA (Transient Ischemic Attack) under the guidance of multimodal MRI (magnetic resonance imaging), and the clinical application of intravenous thrombolysis in patients with ischemic stroke. Methods: Patients with acute ischemic stroke who underwent intravenous thrombolysis in the Department of Neurology from December 2017 to December 2018 were selected. Through CT (computed tomography) screening, 146 patients that met the diagnostic criteria were eventually included. Patients were randomly divided into group A (72 patients) and group B (74 patients). Patients in group A received antiplatelet therapy within 24 h after intravenous thrombolytic therapy for 10 days. The platelet therapy was discontinued when symptomatic intracerebral hemorrhage (SICH) occurred or NIHSS score was ≥4. In group B, after intravenous thrombolysis and antiplatelet therapy, multimodal MRI was used to detect the presence of hemorrhage and other conditions to determine whether to continue the antiplatelet therapy. The NIHSS scores before and after thrombolysis and the 90-day mRS scores after thrombolysis were collected for statistical analysis. Results: The experimental results of each group of patients showed that there was a signif- icant difference in NIHSS scores at admission and 6 h after thrombolysis (P < 0.05). The 30-day mRS score, 90-day mRS score, and prognosis were statistically significant in both groups. The differences in NIHSS scores at 6 h, 24 h, 7 d, and 14 d after thrombolysis and at admission were 1, 1.6, 1.8, and 2.8, which were statistically significant. A comparison of the prognosis of the two groups of patients with hemorrhage 24 h after thrombolysis revealed that the hemorrhage of each patient was improved. Conclusion: In the treatment of ischemic stroke diseases, the utilization of multimodal MRI in clinical intravenous thrombolytic therapy was valuable, which was very sensitive to the detection and display of blood focus. Also, in the selection of treatment methods for clinical thrombolysis in stroke patients, the targeted treatment could be better individualized for each patient.


2011 ◽  
Vol 41 (7) ◽  
pp. 31
Author(s):  
KERRI WACHTER

2017 ◽  
Vol 48 (S 01) ◽  
pp. S1-S45
Author(s):  
N. Plesko-Altermatt ◽  
S. Grunt ◽  
M. Diepold ◽  
E. Perret-Hoigné ◽  
T. Horvath ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document